Nuvation Bio Inc.
NUVB
$8.11
$0.648.57%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 171.47% | 56.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 171.47% | 56.71% | |||
| Cost of Revenue | 30.01% | 23.02% | |||
| Gross Profit | 332.92% | 127.98% | |||
| SG&A Expenses | -2.92% | 8.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.65% | 10.20% | |||
| Operating Income | 11.25% | -7.77% | |||
| Income Before Tax | 5.45% | -10.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.45% | -10.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.45% | -10.84% | |||
| EBIT | 11.25% | -7.77% | |||
| EBITDA | 11.60% | -7.73% | |||
| EPS Basic | 5.95% | -10.18% | |||
| Normalized Basic EPS | 5.91% | -10.07% | |||
| EPS Diluted | 5.95% | -8.25% | |||
| Normalized Diluted EPS | 5.91% | -10.07% | |||
| Average Basic Shares Outstanding | 0.48% | 0.63% | |||
| Average Diluted Shares Outstanding | 0.48% | 0.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||